Back to search

Article

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

2023-01-27

Abstract excerpt

Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts by inducing mutations in the virus genome during replication. Most random mutations are likely to be deleterious to the virus, and many will be lethal, and so molnupiravir-induced elevated mutation rates reduce viral load 2,3 . However, if some patients treated with molnupiravir do not fully clear SARS-CoV-2 infections, there...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18df586e-ed7e-595a-98a6-c6efadec929b
DOI
10.1101/2023.01.26.23284998
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomesDOI 10.1101/2023.01.26.23284998
Select a neighboring publication to make it the new centre.